HealthyDirect · GrowthFit for a long SIP
Franklin India Ultra Short Term Fund
Franklin Templeton Mutual FundIncome/Debt Oriented Schemes - Ultra Short Term Fund2.2 years
The scheme seeks to to provide a combination of regular income and high liquidity by investing primarily in a mix of short term debt and money market instruments.
- NAV
- 11.5951
- 29 Oct 2026
- 1Y
- +6.3%
- Trailing CAGR
- AUM
- ₹299.53 Cr
- 30 Sept 2026
- Volatility
- Low
- 0.4% annualized
Buying brief
Should you add this fund?
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 29 Oct 2026
Stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
In three lines
Fits if · The fund beat the category median in 82% of rolling 1-year windows.
Fits if · Risk-adjusted return sits above the documented risk-free proxy.
Buy checklist
History depth
Fail
2.2 years - thin for judging consistency.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
Pass
0.29% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -0.1%. Ask whether you can hold through a similar fall.
Vs category
n/a
Category relative read still thin.
Manager tenure
Pass
Rohan Maru · 2.1 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Watch
Top 10 holdings ≈ 96.7% of the portfolio.
Evidence supports a shortlist - confirm with peers before you buy elsewhere.
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y+6.3%
- 3Yn/a
- 5Yn/a
- 10Yn/a
- SI+7.1%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y+6.3%
- 3Yn/a
- 5Yn/a
- 10Yn/a
- Since inception
- +7.1%
- Calendar-day CAGR
- Excess 1Y
- -0.1%
- Category median, same plan and option
- 3Y win rate
- n/a
- Windows beating the median
- 3Y percentile
- n/a
- Vs comparable share classes
- SIP 3Y XIRR
- n/a
- Simulated monthly SIP
- Worst rolling 3Y
- n/a
- 0 daily-ending windows
- Median rolling 3Y
- n/a
- Calendar-day CAGR
- Positive rolling 5Y
- n/a
- 0 daily-ending windows
Drawdown
Peak to trough from a running NAV high, with the path and recovery episodes.
- Max drawdown
- -0.1%
- Worst peak-to-trough
- Current
- 0.0%
- At peak
- Current spell
- 0 days
- Days below latest peak
- Time below peak
- +12%
- NAV observations
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 3 days
- 30 recovered episodes
- Longest recovery
- 8 days
- Trough to prior peak
6 Jul 2026 – 13 Jul 2026
Trough 8 Jul 2026 · recovered in 5 days
-0.1%
19 Oct 2026 – 26 Oct 2026
Trough 22 Oct 2026 · recovered in 4 days
-0.1%
11 Mar 2026 – 17 Mar 2026
Trough 13 Mar 2026 · recovered in 4 days
-0.1%
9 Jun 2025 – 16 Jun 2025
Trough 12 Jun 2025 · recovered in 4 days
-0.0%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
36
Vs category
49
Consistency
82
Risk-adjusted
100
Drawdown
100
Mean
74
Decision
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Healthy
Buying stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Why this status
- No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Supporting reads
- The fund beat the category median in 82% of rolling 1-year windows.
- Risk-adjusted return sits above the documented risk-free proxy.
- Peak-to-trough drawdown has stayed shallower than 15%.
Portfolio
30 Sept 2026 · 18 holdings · top 10 are 96.7%.
- Top 5
- 56.0%
- Top 10
- 96.7%
- Largest holding
- 20.0%
- Effective holdings
- 8.7
Cash Margin
Unspecified
20.0%
Cash/Net Current Assets
Unspecified
10.1%
REC LIMITED SR 230-A 7.71 BD 26FB27 FVRS1LAC
Financial
8.7%
SUNDARAM HOME FINANCE LIMITED SR 348 7.70 NCD 26MR27 FVRS1LAC
Financial
8.7%
NATIONAL HOUSING BANK 7.59 BD 08SP27 FVRS1LAC
Financial
8.5%
Worth investigating
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
Mirae Asset Ultra Short-Term Fund
Mirae Asset Mutual Fund
- 1Y
- +6.5%
- 3Y
- +7.3%
- Vol
- 0.4%
- Max DD
- -0.2%
- Sharpe
- 0.91
- 3Y win
- +95%
- Lower volatility
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Caveat: Deeper drawdown
Sundaram Ultra Short Term Fund (Formerly Known as Sundaram Ultra Short Duration Fund)
Sundaram Mutual Fund
- 1Y
- +6.4%
- 3Y
- +7.2%
- Vol
- 0.4%
- Max DD
- -0.2%
- Sharpe
- 2.51
- 3Y win
- +100%
- Lower volatility
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Caveat: Deeper drawdown
Aditya Birla Sun Life Ultra Short Term Fund
Aditya Birla Sun Life Mutual Fund
- 1Y
- +6.4%
- 3Y
- +7.4%
- Vol
- 0.6%
- Max DD
- -1.2%
- Sharpe
- 2.73
- 3Y win
- +100%
- Higher win rate vs category
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown · Higher TER
Axis Ultra Short Term Fund
Axis Mutual Fund
- 1Y
- +6.6%
- 3Y
- +7.4%
- Vol
- 0.5%
- Max DD
- -0.8%
- Sharpe
- 1.63
- 3Y win
- +100%
- Higher win rate vs category
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown · Higher TER
ITI Ultra Short Term Fund
ITI Mutual Fund
- 1Y
- +6.3%
- 3Y
- +7.0%
- Vol
- 0.3%
- Max DD
- -0.2%
- Sharpe
- 0.86
- 3Y win
- 0%
- Lower volatility
- Lower TER
- Higher trailing returns
Caveat: Deeper drawdown